Sutton Wealth Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
CCM
GCM
Sutton Wealth Advisors's MYGN Position: Q1 2023 in Review
Sutton Wealth Advisors sold out of Myriad Genetics (MYGN) in Q1 2023, closing a stake of 1,138 shares — an estimated $16.5K sold.
Sutton Wealth Advisors first reported a position in MYGN in Q1 2017 and held it in 23 quarters. The position peaked at $46.2K in Q3 2018. 190 funds tracked by Wall St. Rank hold MYGN as of Q1 2023.
- Sutton Wealth Advisors reported no remaining Myriad Genetics position as of Q1 2023 after selling out during the quarter.
- Sutton Wealth Advisors sold 1,138 Myriad Genetics shares in Q1 2023, an estimated $16.5K.
- Sutton Wealth Advisors first reported a position in Myriad Genetics in Q1 2017 and held it in 23 quarters.
- Sutton Wealth Advisors's Myriad Genetics position peaked at $46.2K in Q3 2018.
- 190 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2023.
Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.